Burford Capital: profiting from disorder

(Full access for Members only)

Burford Capital: profiting from disorder

23 March 2022

The company featured in this report is truly one of a kind.

Burford Capital is the world's #1 financier of lawsuits, and it is set to benefit mightily from manifold new lawsuit opportunities.

  • There is a specific catalyst coming up in June 2022, which I believe will lead to a short-term hype driving the stock price higher.
  • 2022 and 2023 should see an ongoing revaluation of the company, because of a whole number of catalysts that are gradually going to become apparent.
  • The company's valuation has a quirk that is quite remarkable – you will not have seen anything like it before!
  • Burford Capital operates in a growth market, and disorder in the world will only make its business bigger, stronger, and more profitable.

Outside of the investment case itself, I promise you'll learn something interesting about how the world works.

Not a Member yet? Sign up for a Membership - just USD 49/year.
Already a Member? Log into your account to download the report.

l  Report updates

Not a Member yet? Sign up for a Membership.
Already a Member? Log into your account to download the report updates.

3 April 2023

Report Update (PDF - 0.7MB)

15 August 2022

Report Update (PDF - 0.3MB)

10 June 2022

Report Update (PDF - 0.3MB)

Most recent

Latest reports (for Members only)

Research Report Dr. Martens

Dr. Martens plc: marching towards turnaround

Successful, timeless brands don't come up for a discounted sale very often. Enter Dr. Martens – a true bargain for contrarian investors.

Telco stock with quintuple catalyst

Telco stock with quintuple catalyst

Will we soon see a wave of M&A among European telco companies? This telco stock, in particular, could shine.

Benefitting from France's ageing population

Benefitting from France's ageing population

Following the "ORPEA scandal" that rocked France's care home sector in 2022, this stock should emerge stronger than before.